experimental group:Nitutuzumab combined with concurrent chemoradiotherapy

3 trials

Sponsors

Inner Mongolia Autonomous Region People's Hospital, Baotou Central Hospital

Conditions

Cervical squamous cell carcinomaSquamous cell carcinoma of head and neck

Early Phase 1

Single-arm clinical study of nituzumab combined with concurrent chemoradiotherapy in the treatment of EGFR-positive local advanced head and neck squamous cell carcinoma

RecruitingChiCTR2000039158

Inner Mongolia Autonomous Region People's HospitalSquamous cell carcinoma of head and neck

Start: 2020-12-01Updated: 2021-01-18

Single-arm clinical study of nituzumab combined with concurrent chemoradiotherapy in the treatment of local advanced head and neck squamous cell carcinoma

RecruitingChiCTR2100044511

Baotou Central HospitalSquamous cell carcinoma of head and neck

Start: 2021-04-01Updated: 2021-09-20

Single arm clinical study of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical squamous cell carcinoma

RecruitingChiCTR2100045197

Baotou Central HospitalCervical squamous cell carcinoma

Start: 2021-04-07Updated: 2021-11-08